Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Elna Van Pletzen

The Council of the University of the Free State (UFS) is seeking to co-opt a suitable candidate to serve for a period of four (4) years on the Finance Committee of Council. To this end, nominations for suitably qualified and experienced candidates are invited.

The Finance Committee of Council exercises oversight over the financial and investment portfolio of the UFS.

Candidates must be suitably qualified with requisite knowledge and experience of financial matters (including investments and acquisitions that are material to the UFS’s business). An appropriate qualification in the financial field is required, as is registration with the relevant professional bodies. 

Nominations must be submitted on the prescribed Nomination form, together with detailed curricula vitae, to the Registrar of the UFS at registrar@ufs.ac.za before 16:30 on 12 January 2022.

The Nominations Committee of Council will consider all the nominations and make a recommendation to the Council, which will decide whether to co-opt any of the candidates. 

The Finance Committee meets at least four times per year, or more frequently as may be necessary. 

The Council may decide not to co-opt any of the candidates.  

For enquiries, you may contact Mr NN Ntsababa at registrar@ufs.ac.za or telephone number +27 51 401 3796.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept